Top compounds associated with response to RRP9


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K75293299 CTRPv2 pan-cancer AAC -0.18 0.01
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.02
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.089 0.02
mRNA brivanib CTRPv2 pan-cancer AAC 0.087 0.02
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC 0.083 0.02
mRNA A-770041 GDSC1000 pan-cancer AAC -0.13 0.02
mRNA BX-795 GDSC1000 pan-cancer AAC 0.082 0.02
mRNA Elesclomol GDSC1000 pan-cancer AAC 0.082 0.02
mRNA FQI-2 CTRPv2 pan-cancer AAC 0.077 0.02
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.02
Download CSV